slu pp 332 For Sale

100 mg (not mcg) x 30 capsules

1 capsule with 100 mg SLU-PP 332 =

• 1000 capsules containing 100 mcg
• 500 capsules containing 200 mcg
• 400 capsules containing 250 mcg

This shop was opened because I realized that other shops were charging around 200-400x more for SLU-PP 332

SLU-PP 332 , a synthetic small molecule compound identified as a selective agonist of estrogen-related receptors alpha and gamma (ERRα and ERRγ), has attracted significant academic interest as a research tool for studying the transcriptional regulation of mitochondrial biogenesis, fatty acid oxidation, and metabolic adaptations mimicking exercise in in vitro and in vivo experimental models.

Chemical profile slu pp 332

This product is a high-purity powder (>99%). Unlike peptide compounds, SLU PP 332 is a small-molecule research compound and is supplied as a non-lyophilized powder. It requires reconstitution in an appropriate solvent before experimental use.

• Ingredient: SLU-PP 332
• Total amount: 100 mg in 1 capsule
• Purity: >99% (Determined by HPLC)

Quality assurance

• HPLC analysis: Confirmed purity >99%.
• Mass spectrometry: Confirmed molecular weight and structure.
• Toxicity: Not tested for human safety.

Research Context (Literature Review) slu pp 332

Note: The following information is for educational purposes regarding the chemical properties of this compound and does not constitute a medical claim.

SLU-PP 332 acts as an ERR pan-agonist, with primary activity against ERRα and ERRγ. Both receptors are constitutively active orphan nuclear receptors that regulate the transcription of genes involved in oxidative phosphorylation, mitochondrial biogenesis, and fatty acid metabolism. In experimental models, ERRα and ERRγ activity are closely associated with the adaptive response of muscle tissue to prolonged aerobic exercise.

In vivo studies in rodent models have investigated whether SLU-PP 332 treatment affects exercise capacity, metabolic rate, and body composition under controlled laboratory conditions. These studies remain in the preclinical stage. SLU-PP 332 is being used in academic research as a pharmacological probe to analyze ERR-mediated metabolic signaling.